But growth in health savings accounts to help pay for high deductibles may be slowing.
Industry
Sonex Health of Rochester and Oculogics of Minneapolis land initial venture backing.
The mixed public-private effort with Vaccinex is aiming to bring about a treatment for intractable osteosarcoma.
The deal, which largely involves Surmodics' SurVeil drug-coated balloon, would give Abbott worldwide commercialization rights once the device receives FDA approval.
Latest Articles
The deal, which largely involves Surmodics' SurVeil drug-coated balloon, would give Abbott worldwide commercialization rights once the device receives FDA approval.
The deal marked General Mills re-entry into the pet food industry.
Business is booming for the Baudette-based drug maker.
The imaging company reported nearly $5 million in sales in its fourth quarter, but capped the year with an overall loss of nearly a quarter-million dollars.
State lawmakers try to find a meaningful way to deal with an issue that has been unaddressed for decades - in a place where relationships are often marked by vast power imbalances.
Two entrepreneurs are taking their business back to the basics.
After a successful fundraising campaign, Winona LaDuke is readying her company for wide-scale hemp production, which will be used to make clothing, dietary oils and construction products.
The telecommunications company's purchase of Scott-Rice Telephone will expand its regional presence.
Adogo's John Sturgess hopes to backstop struggling small businesses.
Fast Company highlighted the Minneapolis medical startup on its Top 50 list.
Fourteen jobs will be created by the Canadian company's expansion into the state.
St. Paul has the region's highest percentage of people living in poverty, at 40.8 percent.
Shrinking talent pools of registered nurses and primary-care doctors are a growing issue for hospitals, survey says.
The Minneapolis startup provides free and convenient transportation for low-income, uninsured and vulnerable patients.
The company is currently developing a drug for market approval that treats lower back pain.